The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s atrial fibrillation market report forecasts the atrial fibrillation market size to grow to $18.90 Billion by 2027, with a CAGR (compound annual growth rate) of almost 12%.

Learn More On The Atrial Fibrillation Market Report 2023 – https://www.thebusinessresearchcompany.com/report/atrial-fibrillation-global-market-report

Atrial Fibrillation Market Size Forecast
The global atrial fibrillation market is expected to grow from $10.76 billion in 2022 to $12.07 billion in 2023, at a compound annual growth rate (CAGR) of 12.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The atrial fibrillation market size is expected to grow to $18.90 billion in 2027 at a CAGR of 11.9%.

North America held the largest atrial fibrillation market share, and North America was the fastest-growing region in 2022.

Key Atrial Fibrillation Market Driver ­– Increase In The Geriatric Population
For instance, according to the United Nations Department of Economic and Social Affairs’ September 2020 report, the population aged 65 and older is projected to rise from 9.3% in 2020 to around 16.0% in 2050. Furthermore, according to an October 2021 factsheet published by the World Health Organization, there will be 1.4 billion individuals over the age of 60 in the world by 2030, up from 1 billion in 2020. Therefore, the growing geriatric population is driving the growth of the atrial fibrillation market.

Request for A Sample Of The Global Atrial Fibrillation Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8007&type=smp

Key Atrial Fibrillation Market Trend – Technological Developments
Major companies operating in the healthcare industry are developing new technologies to maintain their position in the atrial fibrillation market. For instance, in October 2020, Biosense Webster, a US-based healthcare company specialized in the diagnosis and treatment of cardiac rhythm abnormalities, received FDA approval for a new technology called The Thermocool Smarttouch Catheter for use in AFib patients. The newly approved technology has been found beneficial for persistent atrial fibrillation, which is defined as AFib occurring for longer than a week but less than a year.

Atrial Fibrillation Market Segment
1) By Type: Surgical, Non-Surgical
2) By Technology: Radiofrequency, Laser, Cryotherapy, Other Technologies
3) By Treatment Type: Pharmacological Treatment, Non-pharmacological Treatment, Maze Surgery, Electric Cardioversion
4) By End User: Hospitals, Electrophysiology Labs, Ambulatory Surgical Centers

Atrial Fibrillation Market Major Players and Strategies
Major players in the atrial fibrillation market are AtriCure Inc., Johnson & Johnson Private Limited, Abbott Laboratories, C.H. Boehringer Sohn AG & Co. KG, Biotronik Se & Co. KG, Boston Scientific Corporation, Bristol-Myers Squibb Company, Biotronik Inc., CardioFocus Inc., Sanofi S.A., Medtronic plc, Biosense Webster Inc., MicroPort Scientific Corporation, Siemens AG, and Pfizer Inc.

In August 2022, Medtronic plc, a US-based medical device company, acquired Affera, Inc. for an undisclosed amount. Through this acquisition, Medtronic expands the company’s cardiac ablation portfolio by including its cardiac mapping and navigation platform, a fully integrated diagnostic, focal pulsed field, and radiofrequency ablation solution. Affera Inc. is a US-based, venture-backed medical device company operating in the atrial fibrillation market.

The Atrial Fibrillation Global Market Report 2023 covers regional data on atrial fibrillation market size, atrial fibrillation market trends and drivers, opportunities, strategies, and atrial fibrillation market competitor analysis. The countries covered in the atrial fibrillation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Atrial fibrillation refers to a disorder of the heart caused by an abnormality in the normal sequence of electrical impulses that changes the rate or rhythm at which the heart beats and begins in the heart’s upper chambers (atria). Electrical impulses can be too fast, too slow, or erratically occurring, resulting in irregular heartbeats.

View More Reports Related To The Atrial Fibrillation Market –
Electrophysiology Devices And Equipment Global Market Report 2023
Wearable ECG Monitors Global Market Report 2023
Anticoagulants Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: